Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/215201
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Isolation and characterization of cytotoxic and insulin-releasing components from the venom of the black-necked spitting cobra Naja nigricollis (Elapidae) |
Autor: | Conlon, J. Michael; Attoub, Samir; Musale, Vishal; Leprince, Jérôme; Casewell, Nicholas R.; Sanz, Libia CSIC ORCID; Calvete, Juan J. CSIC ORCID | Palabras clave: | Cytotoxicity Insulinotropic activity Naja Phospholipase A2 Three-finger toxins |
Fecha de publicación: | 18-mar-2020 | Editor: | Elsevier | Citación: | Toxicon: X 6:100030 (2020) | Resumen: | Four peptides with cytotoxic activity against BRIN-BD11 rat clonal β-cells were purified from the venom of the black-necked spitting cobra Naja nigricollis using reversed-phase HPLC. The peptides were identified as members of the three-finger superfamily of snake toxins by ESI-MS/MS sequencing of tryptic peptides. The most potent peptide (cytotoxin-1N) showed strong cytotoxic activity against three human tumor-derived cell lines (LC50 = 0.8 ± 0.2 μM for A549 non-small cell lung adenocarcinoma cells; LC50 = 7 ± 1 μM for MDA-MB-231 breast adenocarcinoma cells; and LC50 = 9 ± 1 μM for HT-29 colorectal adenocarcinoma cells). However, all the peptides were to varying degrees cytotoxic against HUVEC human umbilical vein endothelial cells (LC50 in the range 2-22 μM) and cytotoxin-2N was moderately hemolytic (LC50 = 45 ± 3 μM against mouse erythrocytes). The lack of differential activity against cells derived from non-neoplastic tissue limits their potential for development into anti-cancer agents. In addition, two proteins in the venom, identified as isoforms of phospholipase A2, effectively stimulated insulin release from BRIN-BD11 cells (an approximately 6-fold increase in rate compared with 5.6 mM glucose alone) at a concentration (1 μM) that was not cytotoxic to the cells suggesting possible application in therapy for Type 2 diabetes. | Descripción: | 8 páginas, 4 figuras, 1 tabla | Versión del editor: | http://dx.doi.org/10.1016/j.toxcx.2020.100030 | URI: | http://hdl.handle.net/10261/215201 | DOI: | 10.1016/j.toxcx.2020.100030 | E-ISSN: | 2590-1710 |
Aparece en las colecciones: | (IBV) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
2020 Toxicon X 6-100030.pdf | 1,33 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
9
checked on 30-abr-2024
SCOPUSTM
Citations
16
checked on 07-may-2024
WEB OF SCIENCETM
Citations
4
checked on 23-feb-2024
Page view(s)
137
checked on 05-may-2024
Download(s)
152
checked on 05-may-2024